Isoprenoids, lipids synthesized from the 5-carbon isoprene units of isopentenyl diphosphate, serve diverse and numerous functions in all living organisms. Isopentenyl diphosphate is formed by one of two pathways (14, 21) , the mevalonate pathway ( Fig. 1) or the nonmevalonate pathway. Mammals and archaea appear to use the mevalonate pathway exclusively, whereas plants use both pathways (19) .
Until recently, all bacteria were thought to use only the nonmevalonate pathway. However, analysis of microbial genome sequences has revealed that the gram-positive cocci and the spirochete Borrelia burgdorferi possess genes that encode only enzymes of the mevalonate pathway (25) , whereas a eubacterial streptomycete strain appears to possess genes that encode both pathways (13, 23) . Genetic disruption experiments have shown that the mevalonate pathway enzymes are essential for the growth of gram-positive cocci (25) . Genes encoding enzymes of the mevalonate pathway are essential for the growth of Staphylococcus aureus, and mutants auxotrophic for mevalonate were severely attenuated for virulence in mice (26) .
In enterococci, the mevalonate pathway genes are clustered at two positions on the genome, and, uniquely, two enzymes of the mevalonate pathway appear to be encoded by a single gene, mvaE (25) . One enzyme is acetoacetyl-coenzyme A (CoA) thiolase (acetyl-CoA C-acetyltransferase, EC 2.3.1.9), the catalyst for the first reaction of the mevalonate pathway ( Fig. 1 ).
2 Acetyl-CoA™3acetoacetyl-CoA ϩ CoASH
Reaction 1 is freely reversible, and thiolysis (reaction 2) is favored.
Acetoacetyl-CoA ϩ CoASH™32 acetyl-CoA
The second enzyme is 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, the best-characterized enzyme of the mevalonate pathway (3) and the target of the statin drugs that lower human blood cholesterol levels (5) . HMG-CoA reductase catalyzes the rate-limiting step of the mevalonate pathway, the reductive deacylation of (S)-HMG-CoA to (R)-mevalonate, reaction 3 ( Fig. 2) . Reaction 3 involves successive formation of enzyme-bound mevaldyl-CoA and mevaldehyde and proceeds in three stages, the first and third of which are reductive.While mevaldehyde is not released during the course of the reaction, HMG-CoA reductase catalyzes two reactions of free mevaldehyde. Reaction 4 resembles the third stage, and reaction 5 resembles the reverse of stages one and two of the overall reaction. HMG-CoA reductase also catalyzes reaction 6, the oxidative acylation of (R)-mevalonate to (S)-HMG-CoA.
There are two structural classes of HMG-CoA reductase (2): the class I enzymes of eukarya and several archaea and the class II HMG-CoA reductases of Pseudomonas mevalonii (11) , Archaeoglobus fulgidus (12), S. aureus (26) , and some streptomycetes (6, 23) . Crystal structures of both classes of the enzyme have been solved (10, 15) . Relative to the class I HMG-CoA reductases, those of class II are over four orders of magnitude less sensitive to inhibition by statin drugs (1, 12, 26) . Enterococci are a major cause of nosocomial infections, and Enterococcus faecalis is responsible for about 85% of all enterococcal infections. Since the mevalonate pathway is essential for the survival of gram-positive cocci, the class II HMG-CoA reductases, and potentially other enzymes of the mevalonate pathway, represent potential targets for development of active-site-directed inhibitors for use as antibiotics against multiple-drug-resistant strains.
We report here the cloning of the mvaE gene of the grampositive pathogen E. faecalis, its expression in Escherichia coli, and the purification and characterization of the gene product, which exists in the enterococci examined as a true bifunctional protein.
MATERIALS AND METHODS
Reagents. Purchased materials included deoxynucleoside triphosphates, T4 polynucleotide kinase, Ts-alkaline phosphatase, isopropyl-␤-D-thiogalactopyranoside (IPTG) and NuPAGE gels (Invitrogen), T4 DNA ligase and restriction enzymes (New England Biolabs), Pwo polymerase (Roche Biochemicals), lysozyme, mutanolysin, and immunoglobulin G horseradish peroxidase (Sigma). Ninitrilotriacetic acid (NTA) agarose (Qiagen) was used for nickel affinity chromatography. Plasmid DNA preparations employed a QIAprep Spin Miniprep Kit (Qiagen), and agarose gel extractions employed a Qiagen Gel Extraction kit. Fluvastatin was a gift from Novartis. Antibodies against the E. faecalis fusion protein were raised in New Zealand white rabbits by Covance Research Products, Denver, Pa. Western blotting employed the NOVEX NuPAGE System (Invitrogen Corp.) and the ECL Western blotting system (Amersham Pharmacia Biotech). Synthetic oligonucleotides were prepared, and automated DNA sequencing was performed in-house at GlaxoSmithKline. Unless otherwise specified, all other reagents were from Sigma.
Plasmids, bacterial strains, and culture media. Expression vector pET28a(ϩ) (Novagen) was modified to allow blunt cloning by replacing the NdeI site with ScaI to generate pET28-6Hblunt. Bacterial strains used included E. coli DH5␣ and BL21(DE3) (Invitrogen), Enterococcus hirae (ATCC 8043), E. faecalis strain 41, and Enterococcus faecium H62738 (GlaxoSmithKline culture collection). Genomic DNA from E. faecalis strain 41 was used for amplification of the mvaE open reading frame. Luria-Bertani (LB) medium and agar (20) supplemented with 50 g of kanamycin per ml served for the growth of E. coli strains. Tryptone soy broth and agar or Todd Hewitt Broth supplemented with 5% (wt/vol) yeast extract served for the growth of enterococcal strains.
Construction of the expression plasmid. The mvaE gene was PCR amplified from E. faecalis genomic DNA by using a forward primer with the start codon changed from TTG to ATG (5Ј-ATGAAAACAGTAGTTATTATTGATGC-3Ј) and a reverse primer (5Ј-ATGTTATTGTTTTCTTAAATCATTTAAAATAG C-3Ј). The resulting 2.4-kb fragment was phosphorylated, gel purified, and ligated into ScaI-digested pET28-6Hblunt that had been dephosphorylated and gel purified (20) . Plasmid DNA isolated from transformed E. coli DH5␣ cells was sequenced to confirm the presence of unaltered mvaE. BL21(DE3) cells were transformed with MvaEef-pET28-6Hblunt to express the N-terminally 6-Histagged protein.
Expression and purification of the gene product. E. coli BL21(DE3) cells transformed with MvaEef-pET28-6Hblunt were grown initially at 37°C. Following addition of 0.5 mM IPTG, growth was continued at 18°C. Harvested cells were washed with 0.9% saline and were suspended in a solution containing 10 mM imidazole, 300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM 
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E. FAECALIS ACETOACETYL-CoA THIOLASE/HMG-CoA REDUCTASE 2117 dithiothreitol, 20 mM HEPES, pH 8.0 (Buffer A), and then were lysed in a French press. The supernatant liquid obtained by centrifugation of the cell lysate in a Beckman L8-70 ultracentrifuge (30,000 rpm, 60 min, 4°C) was applied to an Ni-NTA column. The column was washed with Buffer A and then was eluted successively with 50 and 100 mM imidazole in Buffer A. Fractions with high activity were combined and stored at Ϫ70°C. The most active fractions contained ϳ95% homogeneous His-tagged protein (Fig. 3 ). Overall yields averaged 10 mg/liter. Preparation of enterococcal cell lysates and Western blotting. Proteins present in extracts of E. faecalis, E. hirae, and E. faecium prepared with mutanolysin and lysozyme were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to polyvinylidene difluoride membranes. Following incubation with rabbit antibody raised against the E. faecalis mvaE gene product and incubation with rabbit immunoglobulin G horseradish peroxidase, color was developed with diaminobenzidine tetrahydrochloride and hydrogen peroxide.
Acetoacetyl-CoA thiolase activity. Determination of acetoacetyl-CoA thiolase activity employed a Hewlett-Packard model 8452 diode array spectrophotometer with the cell compartment maintained at 37°C to monitor the change in absorbance at 302 nm that accompanies the formation or thiolysis of acetoacetyl-CoA (4). Standard assay conditions for each reaction studied follow: for reaction 1, synthesis of acetoacetyl-CoA, 1 mM acetyl-CoA, 10 mM MgCl 2 , 50 mM Tris, pH 10.5; reaction 2, thiolysis of acetoacetyl-CoA, 30 M acetoacetyl-CoA, 100 M CoA, 10 mM MgCl 2 , 50 mM Tris-HCl, pH 9.5. Both reactions were initiated by addition of enzyme. Assays employed a final volume of 200 l. For both assays, 1 enzyme unit (eu) represents the synthesis or thiolysis in 1 min of 1 mol of acetoacetyl-CoA. Reported data represent mean values for at least triplicate determinations.
HMG-CoA reductase activity. Spectrophotometric assays of HMG-CoA reductase activity at 37°C monitored the appearance or disappearance of NADP(H) at 340 nm. Standard assay conditions for each reaction studied follow: reaction 3, reductive deacylation of HMG-CoA to mevalonate, 0.4 mM NADPH, 1.0 mM (R,S)-HMG-CoA, 100 mM KCl, and 100 mM K x PO 4 , pH 6.5; reaction 4, reduction of mevaldehyde to mevalonate, 0.4 mM NADPH, 3.8 mM (R,S)-mevaldehyde, 100 mM KCl, and 100 mM K x PO 4 , pH 7.0; reaction 5, oxidative acylation of mevaldehyde to HMG-CoA, 3.0 mM NADP ϩ , 0.5 mM CoA, 2.5 mM (R,S)-mevaldehyde, 100 mM KCl, 100 mM Tris-HCl, pH 9.3; reaction 6, oxidative acylation of mevalonate to HMG-CoA, 3 mM NADP ϩ , 1.5 mM CoA, 4.5 mM (R,S)-mevalonate, 100 mM KCl, and 100 mM Tris-HCl, pH 8. 
RESULTS
The mvaE gene product is a true bifunctional protein. To ascertain whether the mvaE gene product from a representative sample of enterococci undergoes posttranslational cleavage, cell lysates of E. faecalis, E. faecium, and E. hirae were probed with antibodies against the E. faecalis mvaE gene product (Fig. 4) . The mvaE gene product was in all instances present as a single peptide in vivo.
Expression and purification of the E. faecalis mvaE gene product. Expression in E. coli of E. faecalis mvaE yielded a single soluble polypeptide that was readily purified on a nickelchelating column. SDS-PAGE indicated that the product was over 95% homogeneous and had a mass of approximately 90 kDa (Fig. 3, lane 1) . The smaller peptides more prominent in later fractions were recognized by Ni-NTA antibodies (Qiagen), and thus derive from the N terminus of the expressed protein. The calculated molecular mass for the 803-residue polypeptide encoded by mvaE is 86,496 Da. A mass of 88,712 Da estimated for the expressed protein by matrix-assisted laser desorption ionization mass spectrometry, corresponds to the peptide plus the 6-His tag and minus the N-terminal methionine. Peptide sequencing of the purified protein confirmed that this methionine had been removed and that the N-terminal sequence was otherwise intact.
Described below are the kinetic properties of the two catalytic activities, acetoacetyl-CoA thiolase and HMG-CoA reductase.
Acetoacetyl-CoA thiolase. (i) Optimal temperature. Optimum activity both for acetoacetyl-CoA synthesis and for thiolysis of acetoacetyl-CoA occurred at about 37°C (Fig. 5A ). An Arrhenius plot yielded an estimated ⌬H a of 5.3 kcal for thiolysis of acetoacetyl-CoA (Fig. 5A, inset) .
(ii) Optimal pH. Activity was optimal at pH 10.5 for acetoacetyl-CoA synthesis and at pH 9.5 for acetoacetyl-CoA thiolysis (Fig. 6A) . (Table 1) . For reaction 2, the rate of acetoacetyl-CoA thiolysis was measured at several concentrations of CoA and of acetoacetyl-CoA. A plot of 1/[CoASH] (CoASH is the reduced form of CoA) versus 1/(specific activity) at several concentrations of acetoacetyl-CoA yielded parallel lines, consistent with a ping-pong mechanism (Fig. 7A) . For acetoacetyl-CoA thiolysis, the K m for acetoacetyl-CoA was 88 M and the K m for CoA was 10 M (Fig. 7A and inset) . Table 1 summarizes these kinetic parameters and compares them to those of other acetoacetyl-CoA thiolases.
(iv) Inhibition by CoA. CoA inhibited reaction 1 competitive with acetyl-CoA. K i was 0.12 mM and K i /K m AcCoA was 0.19 ( Fig. 7B) .
HMG-CoA reductase. (i) Optimal temperature. Optimal activity for catalysis of reaction 3 occurred at 37°C. An Arrhenius plot of selected data yielded a ⌬H a of 14 kcal (Fig. 5B) .
(ii) Coenzyme specificity. Nucleotide specificity has been established for three class II HMG-CoA reductases. The P. mevalonii enzyme uses NAD(H) exclusively (9), whereas those of S. aureus (26) and A. fulgidus (12) use NAD(H) and NADP(H) equally well. By contrast, E. faecalis HMG-CoA reductase was specific for NADP(H) as the oxidoreductant for all four catalyzed reactions. Activity was undetectable with NAD(H), and even a 10-fold excess of NADH over NADPH did not inhibit reaction 3.
(iii) Optimal pH. The effect of hydrogen ion concentration on the rates of all four catalyzed reactions was determined. Optimal activity was observed at pH 6.5 and 7.0 for reductive reactions 3 and 4 ( Fig. 6B) and at pH 8.0 and 9.5 for oxidative reactions 5 and 6 (Fig. 6C) .
(iv) Kinetic parameters. Kinetic parameters were determined for all four catalyzed reactions. Table 2 compares these data to those for other characterized HMG-CoA reductases. class II enzymes and in the nanomolar range for the class I enzymes (12, 26) . Fluvastatin inhibited reaction 3 competitive with HMG-CoA with a K i of 0.5 mM (Fig. 8) . A K i of 0.2 to 0.5 mM is diagnostic of a class II HMG-CoA reductase (7, 26) . (vi) Inactivation by diethylpyrocarbonate and reactivation by hydroxylamine hydrochloride. In all HMG-CoA reductases studied to date, a histidine plays a key role in catalysis, protonation of the CoA thioanion released during the first stage of the overall reaction (9) . The active-site histidine appears to participate exclusively in the first stage of reaction 3 (7, 8) . We therefore asked whether the histidine-modifying reagent diethylpyrocarbonate (DEPC) inactivated E. faecalis HMG-CoA reductase. DEPC blocked the reductive deacylation of HMGCoA to mevalonate, and subsequent treatment with hydroxylamine hydrochloride restored HMG-CoA reductase activity (Fig. 9A) . By contrast, under conditions where the catalysis of reaction 3 was severely attenuated, DEPC had no detectable effect on reaction 4, the reduction of mevaldehyde to mevalonate (Fig. 9B) .
DISCUSSION
Analysis of complete and partial genome sequences for pathogenic eubacteria revealed the presence of genes thought to encode enzymes of the mevalonate pathway of isopentenyl diphosphate biosynthesis. Subsequent inspection of sequence alignments revealed an unusual feature of isopentenyl diphosphate biosynthesis in enterococci, the presence of the mvaE gene that appears to encode, without interruption, both acetoacetyl-CoA thiolase and HMG-CoA reductase on a single polypeptide (25) . Western blotting of enterococcal extracts was employed to show that the mvaE gene product is indeed expressed in E. faecalis, E. faecium, and E. hirae as a fusion protein and is not posttranslationally cleaved. Radish seedlings express an acetoacetyl-CoA thiolase/HMG-CoA synthase fusion protein (24) . However, the mvaE gene product represents the first bifunctional enzyme of isopentenyl diphosphate bio- The sequence-based inference that E. faecalis HMG-CoA reductase is a class II enzyme was confirmed by the 0.5 mM K i value for inhibition of reaction 3 by the statin drug fluvastatin. This K i value is diagnostic of a class II enzyme (1, 12) . As for both classes of the enzyme, inhibition was competitive with HMG-CoA. As anticipated for an enzyme from a mesophile, the temperature optimum was 37°C. The calculated activation energy ⌬H a of 14 kcal is similar to the ⌬H a of 13 kcal for A. fulgidus HMG-CoA reductase (12) , suggesting that the same step is rate limiting for both enzymes. All four reactions catalyzed by HMG-CoA reductase exclusively employed NADP(H) as the coenzyme. Activity with NAD(H) was below detectable limits, and even a 10-fold molar excess of NAD(H) over NADP(H) did not inhibit reaction 3. The class II HMG-CoA reductase of P. mevalonii uses NAD(H) (11) , and those of S. aureus (26) and A. fulgidus (12) use either NAD(H) or NADP(H). The E. faecalis enzyme is thus presently the only known class II HMG-CoA reductase that is specific for NADP(H).
As previously shown for P. mevalonii HMG-CoA reductase (7), exposure of the fusion protein to the histidine-modifying reagent DEPC severely attenuated catalysis of reaction 3, and subsequent treatment with hydroxylamine hydrochloride restored activity. By contrast, DEPC had no effect on reaction 4. Since hydroxylamine hydrochloride removes the ethoxyformyl group from histidyl but not from cysteinyl or lysyl residues (16) , no catalytically critical cysteinyl or lysyl residue had been modified. These observations implicate a histidine essential for catalysis of reaction 3 but nonessential for reaction 4. This Samples contained fusion protein in a solution containing 250 mM KCl, 10% (vol/vol) glycerol, 250 mM K x PO 4 , pH 6.5. DEPC in ethanol was added to a concentration of 0.8 (}) or 8.0 mM (F). A control contained ethanol but no DEPC (E). After 40 min, hydroxylamine hydrochloride, pH 6.5, was added to a concentration of 700 mM (arrow). Ten-microliter portions removed at the indicated times were assayed for the ability to catalyze reaction 3, the reductive deacylation of HMG-CoA to mevalonate. A o and A are the specific activities at zero time and at the indicated times, respectively. (B) Effect on reaction 4, the reductive deacylation of mevaldehyde to mevalonate. Reaction conditions were as described above but at pH 7.0 and using 8 mM DEPC and an ethanol control (ᮀ). Data for reaction 4 (s) are shown. Also shown are data for reaction 3 (F), included to establish that reaction with DEPC had indeed occurred.
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on October 14, 2017 by guest http://jb.asm.org/ inference is consistent with the proposed role of a histidine that protonates the CoA thioanion released during the first stage of reaction 3 (7-9). Sequence comparisons suggest that the active-site histidine of E. faecalis HMG-CoA reductase is His756 E (Fig. 10) . Characterized acetoacetyl-CoA thiolases are either dimers or tetramers (17) , whereas HMG-CoA reductases typically are either tetramers (10) or hexamers (15, 18) . Gel filtration chromatography and analytical ultracentrifugation suggest that the mvaE gene product exists as a complex mixture of high-molecular-weight species (Hedl et al., unpublished observations). Our future investigations will address the effect of multimeric state on catalytic activity.
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